01858 CHUNLI MEDICAL
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 5.20X | Oper Margin | 16.5% |
---|---|---|---|
LT Debt/Equity | 0.0% | Net Margin | 15.5% |
Total Debt/Equity | 0.0% | Return on Equity | 4.4% |
Price/Book | 2.25X | Return on Assets | 3.6% |
(HKD 17.600) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | 132.92 | 306.22 | 345.01 | 394.28 | 336.31 |
---|---|---|---|---|---|
Net Profit Growth (%) | -56.6 | -11.3 | -12.5 | +17.2 | +27.1 |
Earnings Per Share (HKD) | 0.347 | 0.798 | 0.9 | 1.14 | 0.972 |
Earnings Per Share Growth (%) | -56.6 | -11.3 | -21.1 | +17.2 | +27.9 |
Dividend Per Share (HKD) | 0.145 | 0.397 | 0.342 | 0.153 | No dividend |
P/E* (X) | 50.79 | 22.05 | 19.57 | 15.44 | 18.10 |
Yield (%) | 0.82 | 2.26 | 1.94 | 0.87 | N/A |
Dividend Share (%) | 41.88 | 49.73 | 38.01 | 13.39 | N/A |
Book NAV (HKD) | 7.836 | 8.269 | 7.935 | 7.859 | 3.705 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 487.596 | 380.131 | +28.3 | 540.707 |
Operating Result | 127.309 | 82.247 | +54.8 | 138.46 |
Profit Before Taxation | 127.313 | 83.07 | +53.3 | 138.537 |
Taxation | 12.831 | 4.109 | +212.3 | 12.552 |
Profit /( Loss) After Taxation | 114.482 | 78.961 | +45.0 | 125.985 |
Minority Interests | 0.012 | -0.065 | -118.5 | 0 |
Net Profit | 114.469 | 79.026 | +44.8 | 125.985 |
Earnings Per Share () | 0.3270 | 0.2212 | +47.8 | 0.3545 |
Dividend Per Share () | 0.0000 | 0.0915 | -100.0 | 0.0000 |
Announcement Date | 2025-08-29 | 2024-08-30 | NA | 2023-08-30 |
* Annualised
Last Update Time: 2025-09-08 21:40:25